We at Dalrada Health are committed to reducing the burden of cervical cancer throughout the world and are dedicated to supporting research programs that help save lives – especially in high-risk countries like India.
Dalrada Health Products is pleased to announce it has reached an agreement with a large Mexican distributor to supply its GlanHealth products to healthcare facilities, commercial businesses, and consumers across Mexico.
Dalrada Portfolio Companies Poised To Address Coronavirus, Cervical Cancer And Reducing Co2 Emissions Worldwide In Q2, 2020
Dalrada files a provisional patent with the United States Patent and Trademark Office (USPTO) for their product designed to screen for cervical cancer.
New appointment will strengthen the company’s commitment to global care while signaling further expansion.
Company’s revolutionary product will aid in health screenings and aims to detect early signs of cervical cancer.